Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Non-cash Items: 2012-2025

Historic Non-cash Items for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Sep 2025 value amounting to $4.0 million.

  • Enanta Pharmaceuticals' Non-cash Items rose 185.31% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 185.31%. This contributed to the annual value of $4.0 million for FY2025, which is 185.31% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Non-cash Items of $4.0 million as of FY2025, which was up 185.31% from $1.4 million recorded in FY2024.
  • Enanta Pharmaceuticals' 5-year Non-cash Items high stood at $4.0 million for FY2025, and its period low was $1.4 million during FY2024.
  • For the 3-year period, Enanta Pharmaceuticals' Non-cash Items averaged around $2.8 million, with its median value being $3.1 million (2023).
  • Per our database at Business Quant, Enanta Pharmaceuticals' Non-cash Items plummeted by 54.12% in 2024 and then spiked by 185.31% in 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Non-cash Items (Yearly) stood at $2.5 million in 2021, then rose by 4.01% to $2.6 million in 2022, then climbed by 17.74% to $3.1 million in 2023, then slumped by 54.12% to $1.4 million in 2024, then surged by 185.31% to $4.0 million in 2025.